Mount Sinai Recognized for Excellence in Mitochondrial Care
Icahn School of Medicine is designated a certified mitochondrial care center as part of the newly formed Mitochondrial Care Network
The Icahn School of Medicine at Mount Sinai has been recognized as a certified Mitochondrial Medicine Center by the Mitochondrial Care Network, a newly established collaborative founded by four national mitochondrial disease advocacy groups. The certification recognizes centers for dedication to mitochondrial medicine. Pankaj Prasun, MD, and Bryn Webb, MD, co-directors of the Mitochondrial Medicine Program at Mount Sinai, were also cited as leaders in this field of care.
The Mitochondrial Care Network was formed to formally unify clinicians who provide medical care to individuals with mitochondrial disease; define, design, and implement best practices in mitochondrial medicine; and optimize management and care for affected patients. Factors considered by the Network include current and prior patient volume, multidisciplinary approach, and hospital/center support.
The Mitochondrial Medicine Program at the Mount Sinai Genetics Faculty Practice combines cutting-edge research, state-of-the-art diagnostics, and novel therapies to provide comprehensive disease evaluation, counseling, and management for patients suspected of or diagnosed with mitochondrial disease.
"We are honored to join this world-class group of clinicians and institutions to share our experiences and ideas with," said Dr. Webb. "In addition to being a hub of support, we hope this newly formed network will help raise awareness about the prevalence of mitochondrial disorders."
The Mount Sinai Genetics Faculty Practice and its respective specialty clinics and programs fall under the Department of Genetics and Genomic Sciences, one of the oldest and largest of its kind in the country dedicated to the understanding, prevention, and treatment of birth defects and more than 6,800 rare chromosomal or single gene disorders. The Department is ranked No. 4 nationally for National Institutes of Health funding for genetics research, and is fueled by an institution-wide initiative in Precision Medicine, making it uniquely positioned to make great advances in the field.
“Collaborative medicine has time and time again exemplified strength in numbers,” said Dr. Prasun. “By leveraging both our partnership with the Mitochondrial Care Network and Mount Sinai’s legacy of genomic research and clinical care in genetics, we hope to bring our pioneering ideas to life and improve the standard of care for those with mitochondrial disease.”
Drs. Prasun and Webb say this designation will help them provide care to an increasing number of mitochondrial patients in the era of genomic and precision medicine.
The Icahn School of Medicine at Mount Sinai joins the following list of hospitals and research centers in the Mitochondrial Care Network: Akron Children’s Hospital, Boston Children’s Hospital, Children’s Hospital Colorado, Children’s Hospital of Pittsburgh, Children’s Hospital of Philadelphia, Cleveland Clinic, Columbia University Medical Center, Children’s National Health System, Johns Hopkins University/Kennedy Krieger Institute, Massachusetts General Hospital, Mayo Clinic, Seattle Children’s Hospital, Stanford University, University of California San Diego, University of California San Francisco, University of Maryland and the University of Texas McGovern Medical School.
For more information regarding the Mitochondrial Care Network visit: www.mitonetwork.org.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. The Health System includes approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses across seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, a school of nursing, and schools of medicine and graduate school of biomedical sciences.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York and recognized as one of the world’s top Smart Hospital by Newsweek. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools for National Institutes of Health (NIH) funding and No. 1 among freestanding medical schools, reflecting the strength of its scientific enterprise and leadership in biomedical research.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube. To listen to news and stories from Mount Sinai, visit the Mount Sinai Podcast Network.